BMAL1 and Parkinson disease: The objective of this study is therefore to determine whether the expression levels of five principal clock genes, BMAL1, CLOCK, CRY1, PER1, and PER2 in the PBMCs and circulating melatonin levels are altered in PD patients compared to healthy controls (HC).